JPRN-jRCT1092220301已完成Unknown
ongterm outcome survey of HAL for Medical Use (Lower Limb Type) - Use result survey of HAL for Medical Use (Lower Limb Type)
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 220
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Inclusion criteria must be in accordance with the approved label of HAL for Medical Use (Lower Limb Type)
- •Briefly, the patients of the neuromuscular diseases including spinal muscular atrophy, spinal bulbar muscular atrophy, muscular dystrophy, Charcot-Marie Tooth disease, distal myopathy, sporadic inclusion body myositis, congenital myopathy, and amyotrophic lateral sclerosis who have gait disorder.
- •Body weight ranges from 40 to 100 kg. Body length range approximately from 150 to 190 cm. Lower limb length must be fit to the device length. The patients who are able to wear HAL for Medical Use (Lower Limb Type).
排除标准
- •In the case that patient's length and shape are not fit to HAL for Medical Use (Lower Limb Type). In the case that patient is not allowed to stand and/or walk with HAL for Medical Use (Lower Limb Type). In the case that electrodes are not allowed to be put on the patient's skin because of the patient's skin disease.
研究者
相似试验
已完成
1 期
A study of safety and efficacy of HAL for hemiparesis due to the brain disease in the research project of [A study for efficacy of functional recovery therapy using the Robot Suit HAL for the motor function disorder due to the cerebrospinal diseases, and construction of regional cooperation program of HAL]Stroke (Cerebral infarction, Cerebral hemorrhage)JPRN-UMIN000022410niversity of Tsukuba50
招募中
不适用
HD-med: A longitudinal, observational study to assess medication use, medication efficacy and the role of pharmacogenetics in Huntington*s Disease.Huntington's DiseaseHuntington's chorea (outdated terminology)1008362410028037NL-OMON55123eids Universitair Medisch Centrum391
暂停
不适用
Menopause and ManagementCTRI/2017/09/009856Charutar Vidya Mandal
已完成
3 期
Safety and Efficacy Study of Healos as a Bone Replacement to Treat Degenerative Disc DiseaseDegenerative Disc DiseaseNCT00316121Advanced Technologies and Regenerative Medicine, LLC (ATRM)138
进行中（未招募）
不适用
An open clinical trial on teh efficacy of H-AL pollens (Grass mixture I) administered orally and sublingually in patients with indicated allergen immunotherapy (AIT) with Type I allergy mediated by IgE antibodies (pollens allergy), enrolled in the clinical trial according to the protocol MS01092001 -Type I allergy to pollens mediated by IgE antibodiesEUCTR2004-001521-19-CZSEVAPHARMA a.s.72